Accelerate Your Cell, Gene and Cancer Immunotherapies to Market - Best Rate Ends Friday

Save $400 with the code XB15188BLOG by Friday, July 31 | Register here.

IBC's Cell Therapy Bioprocessing & Commercialization is the most focused conference for cost-effective and efficient cell, gene and immunotherapy approaches that accelerate cell-based product development and production towards commercial success >> Download the full agenda.

Key Topics Include: 
• Applying Genome Editing and Other Disruptive Technologies
• Developing Scalable and Transferrable Manufacturing Processes
• Biopreservation, Cold Chain Management and Patient Delivery
• Developing Successful Business Models
• Fostering Partnerships and Outsourcing Strategies for R&D and Manufacturing
• Pricing, Reimbursement, and Adoption
• Negotiating the Regulatory Pathways to Approval

_______________________________________________________________

Save $400 with the code IMMUNO15BL by Friday, July 31 | Register here.

IBC's Immuno-Oncology is the industry's leading resource for diving into the current issues surrounding efficacy and response rates with first generation immunotherapies to propel the next wave of cancer immunotherapies >> Download the full agenda.

Key Topics Include: 
• Strategies for Combination Therapeutics
• Advances with Checkpoint Inhibitors
• Agnostic Antibody Agents
• Advances in Cancer Vaccines
• Advancing the Next Wave of Cancer Immunotherapies

Share this article with your social network, just click below to share now!

Share |

Unlock the Key to Advancing Immuno-Oncology

As innovations and discoveries in cancer immunotherapies progress at lightning speed, it is critical to understand the successes and challenges with current immunotherapies to separate the hype from the real opportunities. IBC's Immuno-Oncology event develops tactics for improving the efficacy and response rates with first generation immunotherapies and builds a strategy for utilizing combination therapies, t-cell therapies, and checkpoint inhibitors to propel the next wave of cancer immunotherapies.

Download the Immuno-Oncology brochure now to create your pathway for an answer to cancer: http://bit.ly/1O6tbIZ

Immuno-Oncology

Advancing the Next Generation of Cancer Immunotherapies

September 30 – October 1, 2015

Hilton Alexandria Mark Center, Alexandria, VA

Register today and explore the latest advances in Immuno-Oncology to:

Develop next generation immunotherapies by understanding recent advances made with CAR-T and T-Cell therapies, checkpoint inhibitors, cancer vaccines, and agnostic antibodies

Create a successful combination therapy strategy by gaining insights from global leaders on effective combinations

Optimize the discovery and development of your promising immunotherapies by hearing best practices and lessons learned from the first wave of cancer immunotherapies

Download the brochure for full program details: http://bit.ly/1O6tbIZ

Reserve your seat now. Use code IMMUNO15BL to get $100 off the current rate. Register today: http://bit.ly/1O6tbIZ

Best,

The Immuno-Oncology Team 2015

@ibcusa

#Immuno15

Related articles

• New Drug Combination Boosts Immune System and Manipulates Gene Activity To Slow Leukemia
• Researchers develop method to increase T cells in melanoma patients

Share this article with your social network, just click below to share now!

Share |

Celebrate July 4th with 30% Off Select IBC Events!

Take advantage of this special July 4th offer and save 30% off the standard rates to IBC’s Cell Therapy, Bioprocessing & Commercialization, Immuno-Oncology, BioProcess International and Antibody Engineering & Therapeutics when you register by Monday, July 6th.

Cell Therapy, Bioprocessing & Commercialization - Save 30% by using the code XFLASH30 when you register. Visit the event website | Register

Immuno-Oncology - Save 30% by using the code XFLASH30 when you register. Visit the event website | Register

BioProcess International Conference & Exposition - Save 30% by using the code BPIJULY4 when you register.Visit the event website | Register

Antibody Engineering & Therapeutics - Save 30% by using the code AE201530 when you register.Visit the event website | Register


Qualifications, rules and regulations: 
Offer cannot be applied retroactively to confirmed or pending registrations from today's date and prior. 30% discount cannot be combined with any team discounts or other promotions and/or discount offers. Discount is only valid from July 2– July 6, 2015. All registrations are subject to IBC approval. Discount cannot be applied to the Academic/Government Rates.

Share this article with your social network, just click below to share now!

Share |

Advance Your Cell, Gene and Immunotherapy Development | Prices Increase this Friday, 6/19!

Apply the latest scientific and technical innovations to create your pathway towards commercialization by attending IBC's Cell Therapy Bioprocessing & Commercialization and co-located Immuno-Oncology meeting.

$450 registration savings expires this Friday, June 19 - Register today to attend the most focused meeting for understanding today's cost-effective and efficient cell, gene and immunotherapy approaches needed to accelerate your cell-based product towards commercial success.

Register for Cell Therapy Bioprocessing & Commercialization and save an extra $100 with the code: XB15188BLOG| Register Here.

Register for Immuno-Oncology now and save an extra $100 with the code: IMMUNO15BL | Register Here. 

"Cell and gene immunotherapies continue to develop at a rapid pace. IBC continues to grow with this promising field. I will be back in the future!" - Prentice Curry, Kite Pharma Inc. 

Best,
The Cell Therapy and Immuno-Oncology Teams
@IBCUSA

Share this article with your social network, just click below to share now!

Share |

Attend IBC's Immuno-Oncology Conference in Alexandria, VA for FREE as a Guest Blogger

Earn a complimentary all-access pass to Immuno-Oncology conference by serving as a Guest Blogger at the event. As a Guest Blogger, you’ll have access to the Immuno-Oncology event’s comprehensive agenda attracting the best insights from around the world, right in Alexandria, VA in September.

Immuno-Oncology Conference

September 30-October 1, 2015

Hilton Alexandria Mark Center, Alexandria, VA

We are looking for an industry expert to be the face of the IBC's Immuno-Oncology social media campaign. The premise is to provide immuno-oncology and cancer immunotherapies - related articles, whitepapers, and overall original content.

Some of the topics of the conference are: 

• cancer vaccines;
• T-cell therapy;
• agnostic antibodies;
• combination therapies and others.

What You get:

• FREE pass to IBC's Immuno-Oncology conference (valued up to $1,999);
• Extensive social learning activities;
• Exclusive access to a networking community in the industry of your interest!

You also have a chance to GAIN exposure through our five health related-blogs with over 2000 unique visitors monthly each and more than 20 healthcare LinkedIn groups.

Learn more about the IBC's Immuno-Oncology conference event by visiting the website:

Interested and want to learn more about this opportunity please contact Amanda Caterina at acaterina@iirusa.com or directly at 646-895-7339.

We hope to have you join us in Alexandria!

Cheers,

The IBC's Immuno-Oncology Team

@ibcusa

#Immuno15

Visit the website: http://www.ibclifesciences.com/ImmunoOncology/overview.xml

Future of Biopharma Blog http://futurebiopharma.blogspot.com/

Share this article with your social network, just click below to share now!

Share |

Researchers Find New Drugs to Help Fight Cancer

“We're looking at another weapon in the arsenal”

A study recent found that a combination of two drugs that helped allow the immune system to fight the cancer -- ipilimumab and nivolumab -- stopped the deadly skin cancer melanoma from advancing for nearly a year in 58 percent of the cases.  

In addition, there are other studies that have shown promise in treating lung cancer, according to CNN. Those involved in the fight against cancer are divided as to just how excited to get over the promise of immunotherapy in battling cancer.

"Immunotherapy drugs have already revolutionized melanoma treatment, and now we're seeing how they might be even more powerful when they're combined," said Dr. Steven O'Day, an expert with the American Society of Clinical Oncology.

"But the results also warrant caution -- the nivolumab and ipilimumab combination used in this study came with greater side effects, which might offset its benefits for some patients. Physicians and patients will need to weigh these considerations carefully," O'Day explained to CNN.

In the study, 36 percent of the patients receiving the two-drug combination had to stop the therapy due to side effects.  Nell Barrie, a spokeswoman for Cancer Research UK, while calling the results "encouraging" and "promising," told CNN that a lot remains to be learned and the new drugs would not replace any of the existing cancer treatments.

According to Barrie, surgery and chemotherapy or radiotherapy would still be vital. Researchers had yet to study the long-term survival rates for immunotherapy, and the side effects can include inflammation of the stomach and bowel serious enough to require hospitalization, said Barrie.

But Dr. James Larkin, the lead author of the melanoma study, called the results a ‘game changer.’ 

"We've seen these drugs working in a wide range of cancers, and I think we are at the beginning of a new era in treating cancer.”

Barrie said immunotherapy could offer hope to people with cancers that are otherwise difficult to treat. "We're looking at another weapon in the arsenal,” he said. 

Related articles

• Doctors say key to fighting cancer is in patient's own immune system
• Fighting cancer with immune system holds hope
• Immunotherapy combo increases progression-free survival in advanced melanoma patients

Share this article with your social network, just click below to share now!

Share |